Portfolia

08/25/2026

Link to register in bio! In this conversation, you’ll hear firsthand how Hafeezah is transforming mental health care for children, young adults, and families — building fast, accessible support for a population that has too often been left to carry the load alone. Rooted in her own family’s experience navigating the mental health system, Hafeezah turned a deeply personal understanding of what’s missing into Backpack Healthcare’s mission.

08/04/2026

Meet Elizabeth Katkin, one of our newest member across Women’s Health Fund IV and Rising America Fund III.
Partner and General Counsel at Ridgefield Partners. Award-winning author of “Conceivability.” Fertility advocate and legal expert who has spent decades guiding companies through their biggest deals.
This is who makes up Portfolia: women who bring their real expertise, not just their money, to the table. Join us in welcoming Elizabeth!

07/20/2026

And that’s why we have Portfolia! Investing in the companies we want in the world 🌎!

recently opened up about her experience with frozen shoulder while chatting with Michelle Obama on her podcast .

Frozen shoulder affects up to 5 percent of people—usually women—between the ages of 40 and 60, according to the American Academy of Orthopaedic Surgeons.

Despite famous women like Poehler talking about the condition, many people aren’t aware that frozen shoulder is a thing, or what to do about it. There’s also a link between frozen shoulder and menopause, making it a health condition experts say all women should have on their radar.

06/22/2026

11 founders. One Wednesday afternoon. A rare chance to get inside the companies changing women’s health right now. 🌱

Portfolia’s Summer of Women’s Health Innovation brings you face-to-face with the people building real solutions to some of the most underfunded challenges in women’s health — and a chance to invest in what’s next.

📅 June 24 | 11:30 AM PT | Virtual

—— SCHEDULE ——
11:35 – Somer Baburek @ Hera Biotech
11:45 – Laura Yecies @ Osteoboost Health
11:55 – Alex Fennell @ Attn: Grace
12:05 – Akash Bakshi @ YourChoice Therapeutics
☕ Break
12:20 – Mark Kline @ X-Therma
12:30 – Rohit Gupta @ ChronicleBio
12:40 – Maneesh Jain @ X-Therma
12:50 – Darrin Crisitello @ Mercy Bio
☕ Break
1:05 – Noel Pugh @ Lōvu
1:15 – Eric Bennett @ Frontier Bio
1:25 – Ashlee Francis @ FemDx Medsystems
Hundreds have already registered. Come find out how you can be part of what these founders are building.

Link in bio to register. 🔗

HealthTech ImpactInvesting WomenFounders HealthcareInnovation

06/19/2026

Meet Zanoon Nissar / Zanoon Nissar — our newest member. 💚

She co-founded Google’s Giving Week ($90M+ raised annually), built the Bay Area’s largest social impact community for women, and has spent her career making sure women’s health gets the attention — and the funding — it deserves.

Now she’s investing with us. And she’s not alone — 2,000+ women are already here, backing the companies we want to see in the world. For returns and impact. 🙌

Link in bio to learn how to join us.

WomenInBusiness ImpactInvesting FemaleFounders

05/16/2026

~54% of postmenopausal U.S. women — more than 50 million people — have osteopenia, the precursor to osteoporosis. The majority of fragility fractures happen at this stage. Until OsteoBoost, the only options were pharmaceuticals typically prescribed after a fracture had already occurred.
This National Women’s Health Week, we’re spotlighting OsteoBoost — the first and only FDA-cleared prescription medical device for low bone density, named to TIME’s Best Inventions 2025. The wearable belt delivers calibrated low-intensity vibration to the lumbar spine and hips. In an NIH-funded, double-blinded, sham-controlled trial at the University of Nebraska Medical Center: 85% reduction in spine bone density loss, 83% reduction in spine bone strength loss, 55% reduction in hip bone density loss vs. sham.
Since its May 2025 nationwide launch, 2,500+ unique physicians across 30+ academic medical centers have prescribed it.

05/15/2026

60 million peri- and post-menopausal women in the U.S. Over 1 billion women globally projected to be in menopause by 2025. More than half experience vaginal dryness — historically addressable only through hormone therapy or in-office laser procedures costing thousands.
Joylux built a third option. This National Women’s Health Week, we’re spotlighting vFit — the at-home, hormone-free, red-light intimate wellness device co-designed by founder Colette Courtion and OB/GYN Dr. Sarah de la Torre. 1,000+ medical professionals recommend it. 90%+ of users report results. Halle Berry’s Respin partnered with Joylux in September 2024, and distribution now spans Nordstrom, Bloomingdale’s, Ulta, Neiman Marcus, Goop, and Amazon — with global expansion underway via Essity.
Menopause care is moving from clinic to home. Joylux is building the platform.
.

05/14/2026

National Women’s Health Week feels like the perfect moment to welcome Elizabeth Reede as one of our newest members of the Portfolia community—investing in both Women’s Health Fund IV and Rising America III alongside a global network of women backing the future of health, innovation, and impact.
Elizabeth brings a rare interdisciplinary perspective to the future of healthcare. She’s built her career at the intersection of finance, art, and technology—spanning roles as an investment banker, museum curator at the Museum of Modern Art, immersive tech founder, and now AI health entrepreneur.
As Co-Founder & CEO of E Squared Health, she’s building an AI-powered precision health platform designed to integrate lived experience with cross-system data—empowering women with more clarity, autonomy, and proactive control over their health journeys.
See who else has recently joined and learn more about this powerful community of women investors:
https://info.portfolia.com/-new-portfolia-members
Learn more about how Portfolia is celebrating National Women’s Health Week:
https://info.portfolia.com/portfolia-national-womens-health-week-2026

05/14/2026

In 2017, the wearable breast pump category did not exist. Willow shipped the world’s first all-in-one, in-bra pump at CES that year — quiet, app-connected, no tubes, no dangling bottles.
Eight years later, wearable pumps account for 57% of the entire U.S. breast pump market (Circana, 2024) — and in March 2025, Willow acquired Elvie, the global #2, to become the category consolidator. The combined entity is projected to deliver ~50% YoY revenue growth, with an expanded platform spanning pumps, pelvic-floor health (Trainer), and infant sleep (Rise).
When products are designed for women — not redesigned from products built for men — adoption is structurally faster. CEO Kate Ryder is proving it.

05/13/2026

$2.9B post-acquisition valuation. 20M+ users across the U.S., Canada, and Puerto Rico. ~$1.2B in lifetime sales — among the highest commercial pe*******on ever achieved by a D2C health brand.
This National Women’s Health Week, meet Everly Health (Everlywell), founded by Julia Cheek on a simple insight: lab tests are core healthcare infrastructure, and they should be consumer-grade. Today, Everly’s at-home test kits sell through CVS, Target, and direct-to-consumer, spanning fertility, thyroid, metabolism, and 30+ other panels.
Portfolia backed both U.S. unicorns in women’s health. No other firm has both.